Sanofi-Aventis (France) CEO Sees ‘Stunning’ Results for Cancer Drug, BSI-201

June 8, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Bloomberg -- Sanofi-Aventis SA achieved “stunning” results in an ongoing human trial for its novel cancer drug aimed at breast and lung tumors, Chief Executive Officer Chris Viehbacher said.

Twitter
LinkedIn
Facebook
Email
Print

Clinical research Phase III

Sanofi (France)